Log in

Henry Schein Stock Price, News & Analysis (NASDAQ:HSIC)

$62.81
-0.74 (-1.16 %)
(As of 10/21/2019 03:41 AM ET)
Today's Range
$62.77
Now: $62.81
$64.26
50-Day Range
$61.23
MA: $62.57
$64.90
52-Week Range
$56.58
Now: $62.81
$72.81
Volume1.02 million shs
Average Volume956,905 shs
Market Capitalization$9.31 billion
P/E Ratio15.21
Dividend YieldN/A
Beta0.86
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. Read More…

Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNASDAQ:HSIC
CUSIP80640710
Phone631-843-5500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.20 billion
Cash Flow$5.47 per share
Book Value$23.23 per share

Profitability

Net Income$535.88 million

Miscellaneous

Employees18,000
Market Cap$9.31 billion
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.


Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its board has initiated a stock buyback plan on Thursday, December 13th 2018, which permits the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 3.1% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its stock is undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Tuesday, August, 6th. The company reported $0.84 EPS for the quarter, beating the Zacks' consensus estimate of $0.83 by $0.01. The firm had revenue of $2.45 billion for the quarter, compared to the consensus estimate of $2.48 billion. Henry Schein had a net margin of 4.18% and a return on equity of 16.67%. Henry Schein's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.04 EPS. View Henry Schein's Earnings History.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Henry Schein.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of $3.38-3.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.45.

What price target have analysts set for HSIC?

15 brokers have issued 1 year price targets for Henry Schein's shares. Their forecasts range from $62.00 to $96.00. On average, they expect Henry Schein's stock price to reach $73.73 in the next year. This suggests a possible upside of 17.4% from the stock's current price. View Analyst Price Targets for Henry Schein.

What is the consensus analysts' recommendation for Henry Schein?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 4 sell ratings, 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Henry Schein.

Has Henry Schein been receiving favorable news coverage?

Media stories about HSIC stock have trended somewhat positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Henry Schein earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Henry Schein.

Are investors shorting Henry Schein?

Henry Schein saw a increase in short interest in September. As of September 30th, there was short interest totalling 19,310,000 shares, an increase of 6.0% from the August 30th total of 18,220,000 shares. Based on an average trading volume of 1,230,000 shares, the days-to-cover ratio is presently 15.7 days. Approximately 13.2% of the shares of the company are sold short. View Henry Schein's Current Options Chain.

Who are some of Henry Schein's key competitors?

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), CVS Health (CVS), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Citigroup (C), NVIDIA (NVDA), Honeywell International (HON), Nike (NKE), Activision Blizzard (ATVI) and Micron Technology (MU).

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:
  • Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 69)
  • Mr. James P. Breslawski, Vice Chairman & Pres (Age 65)
  • Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 62)
  • Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Director (Age 66)
  • Mr. Mark E. Mlotek, Exec. VP, Chief Strategic Officer & Director (Age 63)

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of of institutional and retail investors. Top institutional investors include PGGM Investments (0.32%), Robeco Institutional Asset Management B.V. (0.10%), State of Alaska Department of Revenue (0.06%), Stephens Investment Management Group LLC (0.05%), Nisa Investment Advisors LLC (0.03%) and Zurcher Kantonalbank Zurich Cantonalbank (0.03%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Mark E Mlotek, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel. View Institutional Ownership Trends for Henry Schein.

Which institutional investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Envestnet Asset Management Inc., Nisa Investment Advisors LLC, Gateway Investment Advisers LLC, First Hawaiian Bank, Stephens Inc. AR, Wedbush Securities Inc. and Neville Rodie & Shaw Inc.. Company insiders that have sold Henry Schein company stock in the last year include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel. View Insider Buying and Selling for Henry Schein.

Which institutional investors are buying Henry Schein stock?

HSIC stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, State of Alaska Department of Revenue, Robeco Institutional Asset Management B.V., Zurcher Kantonalbank Zurich Cantonalbank , Stephens Investment Management Group LLC, Bailard Inc., Schwab Charitable Fund and Pacer Advisors Inc.. View Insider Buying and Selling for Henry Schein.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $62.81.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $9.31 billion and generates $13.20 billion in revenue each year. The company earns $535.88 million in net income (profit) each year or $4.13 on an earnings per share basis. Henry Schein employs 18,000 workers across the globe.View Additional Information About Henry Schein.

What is Henry Schein's official website?

The official website for Henry Schein is http://www.henryschein.com/.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]


MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  298 (Vote Outperform)
Underperform Votes:  527 (Vote Underperform)
Total Votes:  825
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe HSIC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSIC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Monthly Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel